Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • News

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • DIAGNOSIS AND PROGNOSIS EVALUATION OF SEVERE PNEUMONIA BY LUNG ULTRASOUND SCORE COMBINED WITH SERUM INFLAMMATORY MARKERS.

    Bo Fu, Peng Zhang, JunHua Zhang
    e2023057
    2023-10-30
    https://doi.org/10.4084/MJHID.2023.057
    807
    PDF: 575
    HTML: 143
  • TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML

    Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi
    e2023038
    2023-06-29
    https://doi.org/10.4084/MJHID.2023.038
    2123
    PDF: 1692
    HTML: 377
  • HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?

    Antoine Thyss, Esma Saada, Lauris Gastaud, Frédéric Peyrade, Daniel Ré
    e2014050
    2014-07-01
    https://doi.org/10.4084/mjhid.2014.050
    2882
    PDF: 1360
    HTML: 3569
    Untitled: 192
    Untitled: 202
    Untitled: 177
  • ANALYSIS OF PROGNOSTIC RISK FACTORS OF BLOODSTREAM INFECTIONS IN BEIJING COMMUNITIES: A RETROSPECTIVE STUDY FROM 2015 TO 2019

    Yan Liu, Beichen Cui, Chunmei Pi, Xiaohong Yu, Zhiwei Liu, Xiang Li, Liping Ma, Cong Wang
    e2021060
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.060
    843
    PDF: 351
    HTML: 128
  • PROLIFERATION AND APOPTOSIS OF B-CELL LYMPHOMA CELLS UNDER TARGETED REGULATION OF FOXO3 BY miR-155 miR-155, FOXO3, B-cell lymphoma, proliferation, apoptosis, clinical characteristics

    Xiaoqiang Zheng, Hongbing Rui, Ying Liu, Jinfeng Dong
    e2020073
    2020-11-02
    https://doi.org/10.4084/mjhid.2020.073
    766
    PDF: 89
    HTML: 138
  • THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA

    Yingying Li, Yang Li, Wenguo Cheng
    e2025073
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.073
    477
    PDF: 243
    HTML: 78
  • ASSOCIATION BETWEEN LEUKEMIC EVOLUTION AND UNCOMMON CHROMOSOMAL ALTERATIONS IN PEDIATRIC MYELODYSPLASTIC SYNDROME

    Viviane Lamim Lovatel, Beatriz Ferreira da Silva , Eliane Ferreira Rodrigues , Maria Luiza Rocha da Rosa Borges , Rita de Cássia Barbosa Tavares, Ana Paula Silva Bueno, Elaine Sobral da Costa, Terezinha de Jesus Marques , Teresa de Souza Fernandez
    e2024003
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.003
    1172
    PDF: 1371
    HTML: 134
  • TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML

    Buket Altinok Gunes, Tulin OZKAN, Aynur Karadag Gurel, Semih Dalkilic, Nevin Belder, Zeynep Ozkeserli, Hilal Ozdag Sevgili, Meral Beksac, Nilgun Sayinalp, Abdullah Munci Yagci, Asuman Sunguroglu
    e2024058
    2024-06-29
    https://doi.org/10.4084/MJHID.2024.058
    1042
    PDF: 1154
    Suppl. Files: 569
    HTML: 88
  • RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM

    Ugo Testa, Elvira Pelosi, Germana Castelli, Giuseppe Leone
    e2023062
    2024-06-29
    https://doi.org/10.4084/MJHID.2024.062
    1190
    PDF: 1062
    HTML: 201
  • DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES

    Prof. Giuseppe Leone, Emiliano Fabiani, Maria Teresa Voso
    e2022030
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.030
    1375
    HTML: 394
    PDF: 819
  • RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES

    Julie Schanz, Friederike Braulke, Detlef Haase
    e2015034
    2015-04-23
    https://doi.org/10.4084/mjhid.2015.034
    3771
    PDF: 1661
    HTML: 11590
    Figures Haase: 198
  • INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE

    Duni Sawadogo, Aissata Tolo, Hermance Kassi, Mahawa Sangare, Andre Inwoley
    e2013023
    2013-04-10
    https://doi.org/10.4084/mjhid.2013.023
    1957
    PDF: 711
    HTML: 683
    Table1: patient's characteristics: 155
    Table 2: profile of each patient: 178
  • PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA

    Annarosa Cuccaro, Francesca Bartolomei, Elisa Cupelli, Stefan Hohaus
    e2014053
    2014-07-04
    https://doi.org/10.4084/mjhid.2014.053
    3310
    PDF: 1963
    HTML: 7472
  • PLASMA CELL LEUKEMIA UPDATE ON IMMUNOPHENOTYPE, MOLECULAR CHARACTERISTICS, AND THERAPY. The second part of plasma cell neoplasms with spreading in the blood and tissues Plasma Cell Leukemia

    Giuseppe G.M. Leone, Ugo Testa
    e2025080
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.080
    1044
    PDF: 352
    Html: 104
  • CUPROPTOSIS: A REVIEW ON MECHANISMS, ROLE IN SOLID AND HEMATOLOGICAL TUMORS, AND ASSOCIATION WITH VIRAL INFECTIONS

    MAURIZIO MARTINI, Pietro Tralongo, Mariagiovanna Ballato, Vincenzo Fiorentino, Walter Giordano, Valeria zuccalà, Cristina Pizzimenti, Arianna Bakacs, Antonio Ieni, Giovanni Tuccari, Guido Fadda, Luigi Maria Larocca
    e2025052
    2025-06-29
    https://doi.org/10.4084/MJHID.2025.052
    1698
    PDF: 977
    HTML: 186
  • PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma

    Ugo Testa; Giuseppe G.M. Leone
    e2025005
    2024-12-31
    https://doi.org/10.4084/MJHID.2025.005
    2449
    HTML: 271
    PDF: 868
  • EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN

    Massimiliano Salati, Marina Cesaretti, Matteo Macchia, Mufid El Mistiri, Massimo Federico
    e2014048
    2014-06-29
    https://doi.org/10.4084/mjhid.2014.048
    3531
    PDF: 1177
    HTML: 4998
    Incidence age-standardized rates for HL across the Mediterranean basin: 201
  • NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?

    Alessandro Corso, Silvia Mangiacavalli
    e2017053
    2017-08-18
    https://doi.org/10.4084/mjhid.2017.053
    3249
    PDF: 1709
    HTML: 1084
  • GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS

    Angela Stoddart, Megan E. McNerney, Elizabeth Bartom, Rachel Bergerson, David J. Young, Zhijian Qian, Jianghong Wang, Anthony A. Fernald, Elizabeth M. Davis, Richard A. Larson, Kevin P. White, Michelle M. Le Beau
    e2011019
    2011-05-16
    https://doi.org/10.4084/mjhid.2011.019
    2580
    PDF: 798
    HTML: 5214
  • DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA

    Sabina Chiaretti, Gina Zini, Renato Bassan
    e2014073
    2014-10-24
    https://doi.org/10.4084/mjhid.2014.073
    9051
    PDF: 6057
    HTML: 87956
    Fig.1b: 184
    Fig.1c: 188
    Fig.2a: 176
    Fig.2b: 175
    Fig.4: 188
    Fig.2c: 183
    Fig.3: 181
    Tab.1: 225
    Tab.2: 206
    Tab.3: 188
    Tab.4: 220
    Fig1a: 181
  • TREATMENT OF ADOLESCENT AND YOUNG ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

    Josep-Maria Ribera, Jordi Ribera, Eulàlia Genescà
    e2014052
    2014-07-02
    https://doi.org/10.4084/mjhid.2014.052
    2605
    PDF: 1327
    HTML: 5908
  • PROGNOSTIC SIGNIFICANCE OF NRAS GENE MUTATIONS IN CHILDREN WITH ACUTE MYELOGENOUS LEUKEMIA

    Rabab Aly, Mohamed R. El-sharnoby, Adel A. Hagag
    e2011055
    2011-11-28
    https://doi.org/10.4084/mjhid.2011.055
    1871
    PDF: 758
    HTML: 1518
  • MICRORNA-181A-3P AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER FOR ACUTE MYELOID LEUKEMIA

    Xiaoling Ma
    e2020012
    2020-02-26
    https://doi.org/10.4084/mjhid.2020.012
    1675
    PDF: 1029
    HTML: 204
  • SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis

    Roberta Zanotti, Massimiliano Bonifacio, Ilaria Tanasi, Donatella Schena, Giovanni Orsolini, Morena Tebaldi, Lara Crosera, Francesca Mastropaolo, Elisa Olivieri, Dr. Patrizia Bonadonna
    e2021068
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.068
    1525
    PDF: 941
    HTML: 222
  • PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations

    Michele Bibas
    e2024007
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.007
    3549
    PDF: 2411
    HTML: 1463
  • PROGNOSTIC IMPACT OF NEUROPILIN-1 EXPRESSION IN EGYPTIAN CHILDREN WITH B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA

    adel abd elhaleim hagag, Nahla A Nosair
    e2015009
    2014-12-28
    https://doi.org/10.4084/mjhid.2015.009
    1639
    PDF: 819
    HTML: 2109
  • SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML

    Francesco D'Alò, Luana Fianchi, Emiliano Fabiani, Marianna Criscuolo, Mariangela Greco, Francesco Guidi, Livio Pagano, Giuseppe Leone, Maria Teresa Voso
    e2011052
    2011-11-28
    https://doi.org/10.4084/mjhid.2011.052
    3584
    PDF: 886
    HTML: 6711
  • HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients

    Wenshan Yang, Wei Dong
    e2025029
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.029
    2196
    PDF: 989
    HTML: 147
    Suppl. Files: 512
  • EXTRAMEDULLARY INVOLVEMENT IN ACUTE MYELOID LEUKEMIA. A SINGLE CENTER TEN YEARS EXPERIENCE

    Luana Fianchi, Martina Quattrone, Marianna Criscuolo, Silvia Bellesi, Giulia Dragonetti, Alessio Maria Edoardo Maraglino, Matteo Bonanni, Patrizia Chiusolo, Simona Sica, Livio Pagano
    Page e2021030
    2021-04-29
    https://doi.org/10.4084/MJHID.2021.030
    2395
    PDF: 863
    HTML: 363
  • SOLITARY PLASMACYTOMA

    Sara Grammatico, Emilia Scalzulli, Maria Teresa Petrucci
    e2017052
    2017-08-23
    https://doi.org/10.4084/mjhid.2017.052
    3851
    PDF: 2175
    HTML: 1221
    fIGURES 1,2: 213
  • THERAPY-RELATED MYELOID NEOPLASMS IN PATIENTS TREATED FOR HODGKIN LYMPHOMA

    Dennis A Eichenauer, Andreas Engert
    e2011046
    2011-10-24
    https://doi.org/10.4084/mjhid.2011.046
    2265
    PDF: 752
    HTML: 1201
  • SYSTEMIC MASTOCYTOSIS: MOLECULAR LANDSCAPE AND IMPLICATIONS FOR TREATMENT

    Cecilia Monaldi, Sara De Santis, Manuela Mancini, Samantha Bruno, Michele Cavo, Simona Soverini
    e2021046
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.046
    1389
    PDF: 684
    HTML: 247
  • IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS

    Efterpi Kostareli, Maria Gounari, Andreas Agathangelidis, Kostas Stamatopoulos
    e2012052
    2012-08-09
    https://doi.org/10.4084/mjhid.2012.052
    3055
    PDF: 875
    HTML: 7163
    Kost Fig1: 182
    Kost Fig 2: 177
    Kost Fig3: 174
    Kost Fig 4: 190
    Kost Fig5: 184
    Kost fig 6: 173
  • NG2 MOLECULE EXPRESSION IN ACUTE LYMPHOBLASTIC LEUKEMIA B CELLS: A FLOW-CYTOMETRIC MARKER FOR THE RAPID IDENTIFICATION OF KMT2A GENE REARRANGEMENTS

    Maria Laura Bisegna, Nadia Peragine, Loredana Elia, Mabel Matarazzo, Maria Laura Milani, Stefania Intoppa, Mariangela Di Trani, Francesco Malfona, Maurizio Martelli, Maria Stefania De Propris
    e2024018
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.018
    953
    PDF: 1275
    Suppl. Files: 829
    HTML: 170
  • TUBERCULOSIS IN CHILDREN

    Susanna Esposito
    e2013064
    2013-11-04
    https://doi.org/10.4084/mjhid.2013.064
    3127
    PDF: 1319
    HTML: 4817
  • TYROSINE KINASE INHIBITORS AND PREGNANCY

    Elisabetta Abruzzese, Malgorzata Monika Trawinska, Paolo De Fabritiis, Alessio Pio Perrotti
    e2014028
    2014-04-07
    https://doi.org/10.4084/mjhid.2014.028
    3557
    PDF: 1635
    HTML: 2674
  • Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio

    Dr. Enrica A. Martino, Dr. G. Mele, Dr. F. Morabito, Dr. M. Gentile, Dr. E. Vigna
    e2025006
    2024-12-31
    https://doi.org/10.4084/MJHID.2025.006
    2169
    PDF: 1586
    HTML: 265
  • INFECTIONS IN MYELODYSPLASTIC SYNDROME IN RELATION TO STAGE AND THERAPY

    Giuseppe Leone, Livio Pagano
    e2018039
    2018-07-01
    https://doi.org/10.4084/mjhid.2018.039
    4177
    PDF: 1453
    HTML: 594
  • TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH HIGH WHITE CELL BLOOD COUNTS.

    Charicleia Kelaidi, Lionel Ades, Pierre Fenaux
    e2011038
    2011-09-08
    https://doi.org/10.4084/mjhid.2011.038
    2473
    PDF: 946
    HTML: 2339
  • THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA

    Xenofon Papanikolaou, Bart Barlogie, Saad Usmani
    e2011047
    2011-10-24
    https://doi.org/10.4084/mjhid.2011.047
    2452
    PDF: 784
    HTML: 1735
  • MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)

    Ibrahim C. Haznedaroglu
    e2014009
    2013-12-31
    https://doi.org/10.4084/mjhid.2014.009
    3935
    PDF: 1492
    HTML: 9188
    Untitled: 277
    Untitled: 183
    Untitled: 168
    Untitled: 164
    Untitled: 180
    Untitled: 338
  • MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY

    Francesco Lococo, Roberto Latagliata, Massimo Breccia
    e2013045
    2013-06-08
    https://doi.org/10.4084/mjhid.2013.045
    2760
    PDF: 1118
    HTML: 3283
  • “IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”

    Sara Martinelli, Antonio Cuneo, Gian Matteo Rigolin
    e2016047
    2016-10-15
    https://doi.org/10.4084/mjhid.2016.047
    3994
    PDF: 1051
    HTML: 3590
    Untitled: 177
    Cneo. Fig.1: 113
    Untitled: 104
    Untitled: 126
    Untitled: 131
  • The THE PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW: PART 2-FOCUS ON THERAPY

    Michele Bibas
    e2024015
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.015
    1720
    PDF: 1664
    HTML: 812
  • PROGNOSIS AND THERAPY WHEN ACUTE PROMYELOCYTIC LEUKEMIA AND OTHER “GOOD RISK” ACUTE MYELOID LEUKEMIAS OCCUR AS A THERAPY-RELATED MYELOID NEOPLASM

    Richard A. Larson, Michelle Le Beau
    e2011032
    2011-07-08
    https://doi.org/10.4084/mjhid.2011.032
    2824
    PDF: 915
    HTML: 1870
  • TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS

    Luca Maurillo, Francesco Buccisano, Maria Ilaria Del Principe, Chiara Sarlo, Luigi Di Caprio, Concetta Ditto, Federica Giannotti, Daniela Nasso, Eleonora Ceresoli, Massimiliano Postorino, Marco Refrigeri, Sergio Amadori, Adriano Venditti
    e2013032
    2013-06-03
    https://doi.org/10.4084/mjhid.2013.032
    2801
    PDF: 1007
    HTML: 5519
  • PROGNOSTIC VALUE OF BRAIN AND ACUTE LEUKEMIA CYTOPLASMIC GENE EXPRESSION IN EGYPTIAN CHILDREN WITH ACUTE MYELOID LEUKEMIA

    adel abd elhaleim hagag
    e2015033
    2015-04-19
    https://doi.org/10.4084/mjhid.2015.033
    2098
    PDF: 827
    HTML: 1140
  • CLINICAL CHARACTERISTICS AND PROGNOSTIC FACTORS IN PRIMARY BREAST DIFFUSE LARGE B-CELL LYMPHOMA

    guangliang Chen, Dou-dou Li, Sufen Sufen, Shiyu Jiang, Qunling Zhang, jia jin, Zuguang Xia, Yizhen Liu, Xiaojian Liu, Yanzhe Zhu, Yu Chen, Lingli Gu, Xiaonan Hong, Junning Cao, Rong Tao, Fangfang Lv
    e2022066
    2022-08-27
    https://doi.org/10.4084/MJHID.2022.066
    972
    PDF: 631
    HTML: 234
  • EBV CHRONIC INFECTIONS

    Eligio Pizzigallo, Delia Racciatti, Valeria Gorgoretti
    e2010022
    2010-08-09
    https://doi.org/10.4084/mjhid.2010.022
    3477
    PDF: 1577
    HTML: 7804
  • NOVEL DRUGS IN FOLLICULAR LYMPHOMA

    Giuseppe Rossi, Antonella Anastasia
    e2016061
    2016-11-01
    https://doi.org/10.4084/mjhid.2016.061
    4313
    PDF: 1488
    HTML: 1547
    Untitled: 225
1 - 50 of 387 items 1 2 3 4 5 6 7 8 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy